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Abstract 
Ubiquitin-like (UBL) - ubiquitin-associated (UBA) proteins, including Dsk2 and Rad23, act as 
delivery factors that target polyubiquitinated substrates to the proteasome. We report here that 
the Dsk2 UBL domain is ubiquitinated in yeast cells and that Dsk2 ubiquitination of the UBL 
domain is involved in Dsk2 stability, depending on the Dsk2 UBA domain. Also, Dsk2 lacking 
ubiquitin chains impaired ubiquitin-dependent protein degradation and decreased the interaction 
of Dsk2 with polyubiquitinated proteins in cells. Moreover, Dsk2 ubiquitination affected ability 
to restore the temperature-sensitive growth defect of dsk2 . These results indicate that 
ubiquitination in the UBL domain of Dsk2 has in vivo functions in the ubiquitin-proteasome 
pathway in yeast. 
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Introduction 
The ubiquitin-proteasome system regulates various biologic processes by mediating the 
degradation of many short-lived cellular proteins. Ubiquitinated proteins are degraded in steps: 
ubiquitination, recognition, delivery, and degradation by the proteasome. The processes by 
which ubiquitinated proteins are recognized and delivered to the proteasome are regulated 
through ubiquitin-like (UBL)-ubiquitin-associated (UBA) proteins and ubiquitin receptors (for 
review, see [1,2]. UBL-UBA proteins bind polyubiquitinated proteins and deliver them to the 
proteasomal receptors Rpn1, Rpn10 and Rpn13 [3-8]. UBL-UBA proteins also interact and 
cooperate with specific E3 and E4 enzymes [9,10] and E1 activity [11]. Furthermore, Rpn10 
and Dsk2 can function together as a polyubiquitin-chain length sensor [12], and several UBL 
domain-binding proteins interact with UBL-UBA proteins and are positively and negatively 
involved in the delivery pathway [6,13,14]. Together, these findings indicate that UBL-UBA 
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proteins have a regulatory role in the recognition and delivery of polyubiquitinated proteins. 
In yeast, three UBL-UBA proteins; Rad23, Dsk2, and Ddi1, are known to be such delivery 
proteins. In this process, “mobile” UBL-UBA proteins interact with the proteasome together 
with polyubiquitinated proteins, and they are selectively degraded. UBL-UBA proteins that 
interact with the proteasome, however, can escape degradation. It has been demonstrated that 
the Rad23 UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from 
proteasomal degradation and the UBA2 domain deletion mutant is unstable [15]. As predicted 
by Walters [16], intra-molecular interactions between the UBL and UBA domains seem to 
contribute to the stability of Rad23/hHR23A.  
Budding yeast Dsk2 is a UBL-UBA protein that helps deliver polyubiquitinated proteins to 
the proteasome [17-19]. To better understand the molecular mechanisms of UBL-UBA proteins 
in the ubiquitin-proteasome pathway, we investigated the role of Dsk2 ubiquitination using 
lysine mutants of the Dsk2 UBL domain. Dsk2 is quite stable in yeast [20], but we show here 
that Dsk2 is ubiquitinated in yeast in the UBL domain, and that ubiquitin chains of the UBL 
domain mediate the degradation of Dsk2 defective in the UBA domain. Dsk2 ubiquitination of 
UBL domains also affected ubiquitin-dependent degradation in yeast. We discuss physiological 
relevance of the ubiquitination of the Dsk2 UBL domain in Dsk2 stability as well as in the 
ubiquitin-proteasome pathway. 
 
Materials and methods 
Strains, plasmids, and media 
Saccharomyces cerevisiae YPH499 (MATa ade2-101 leu2-  trp1- 63 ura3-52 lys2-801 
his3- 200), used as the wild-type strain, was previously described [17]. Mutant strains (dsk2 , 
rpn1-821, and pre2-75, dsk2 , dsk2 rad23 ), media, and growth conditions were 
described previously [17,21]. Plasmids carrying the glutathione S-transferase (GST)-tagged 
version pEG-KG-DSK2, were described previously [17]. Multi-copy plasmids 
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pGAL1-YEplac195 harboring DSK2 or pGAL1-YEplac112 harboring His6-T7-ubiquitin were 
used for the ubiquitination assay [17]. A single-copy plasmid pRS316 harboring DSK2 and its 
endogenous promoter was used for complementation of dsk2 . The growth of a dsk2 rad23  
strain transformed by this plasmid was tested on plates of minimal medium containing 2% 
glucose minus uracil [17]. For complementation of uracil auxotrophy, a single-copy plasmid, 
pRS314, harboring URA3-fused DSK2 was transformed into YPH499 and these transformed 
strains were incubated on plates of minimal medium containing 2% glucose minus uracil and 
tryptophan at 30oC for 3 days. 
  
Construction of Dsk2 mutants 
DSK2 deletion mutants and Dsk2 UBA domain mutants were described previously [17,21]. The 
arginine-substituted mutants of the UBL domain were constructed by site-directed polymerase 
chain reaction (PCR) methods using pEG-KG-DSK2 as the template. The mutated XbaI-HindIII 
fragment was subcloned into the XbaI-HindIII sites of pEG-KG-DSK2, pGAL1-YEplac195, and 
pRS316. To construct a series of UBL- and UBA-substituted mutants (UBL/UBA mutant), a 
KpnI- HindIII fragment from UBA mutants was subcloned into the KpnI-HindIII sites of a 
plasmid harboring mutated DSK2 in the UBL domain (pEG-KG-mutant DSK2). To generate 
URA3-fused DSK2, each DNA fragment containing Dsk2 5’UTR (BamHI-EcoRI), URA3 
(EcoRI-EcoRI), DSK2 (EcoRI-HindIII), and Dsk2 3’UTR (HindIII-ClaI) was constructed by 
PCR and these DNA fragments were fused into pBluescript-IISK+ 
(5’UTR-URA3-DSK2-3’UTR in pBS-IISK+). The BamHI-XhoI fragment of this plasmid was 
then subcloned into the BamHI/XhoI sites of pRS314. 
 
Binding assay and degradation of Dsk2 in vivo  
For the binding assay, His6-T7-ubiquitin and Dsk2 were co-expressed in yeast, and cell extracts 
in lysis buffer containing 1 mM EGTA instead of EDTA were incubated with Talon 
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metal-affinity resin (CLONTECH) [17]. Talon resin or glutathione-Sepharose beads were used 
to pull down His6-T7-ubiquitin, and the bound material was immunoblotted with anti-Dsk2 or 
anti-T7 antibodies. For detection of ubiquitinated Dsk2, Dsk2 was co-expressed with 
His6-T7-ubiquitin in yeast, and the Talon resin pull-down was immunoblotted with anti-Dsk2 
antibody. For the degradation assay, GST-DSK2 in pEG-KG or DSK2 in pGAL1-YEplac195 
was transformed into yeast. Dsk2 was overexpressed for 4 h by the addition of 2% galactose. 
Cell extracts were collected at 30 min intervals after the induction was shut off by adding 
dextrose to the medium, followed by immunoblotting with anti-Dsk2, anti-Cdc28, anti-Ddi1 
(UBL-UBA protein), and anti-mAb414 (nuclear NPC) antibodies. For degradation of N-end rule 
substrate Leu- -gal [6], Dsk2 or Dsk2-KR in YCplac22 was co-expressed with Ub-Leu- -gal in 
dsk2  strain under the control of the GAL1 promoter. After incubation at 30oC for 4 h, 
galactose-induction was shut off and cell samples were taken at 20 min intervals followed by 
immunoblotting with anti- -gal antibody. 
 
Results 
The UBL domain of Dsk2 is required for ubiquitin-dependent degradation of UBA 
domain-defective Dsk2.  
Dsk2 is considered to be a stable protein [20], but Dsk2/Rad23 mutants that are defective in the 
UBA domain become unstable [15]. To investigate the role of UBL and UBA domains of Dsk2 
in its own stability, we constructed a series of Dsk2-truncated mutants (Fig. 1A) and confirmed 
that UBA-defective Dsk2 was unstable (lanes 5, 6). This instability could be recovered by 
deleting the UBL domain (lane 8), indicating the requirement of the UBL domain for Dsk2 
instability.  
Two different types of experiments were then performed to test whether this instability 
depends on the ubiquitin-proteasome pathway. First, the UBA mutant (LL368AA, see Fig. 1A) 
was induced into proteasome mutant strains pre2 and rpn1 followed by immunoblotting with 
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anti-Dsk2 antibody (Fig. 1B). LL368AA was stabilized in pre2 (lane 4) and rpn1 (lane 6), 
whereas LL368AA was barely detectable in the wild-type strain (lane 2). In comparison, 
wild-type Dsk2 was stable (lanes 1, 3, 5). To confirm this result, LL368AA was expressed in a 
dsk2  background (Fig 1C). Again, LL368AA expressed in dsk2  was rapidly degraded, whereas 
LL368AA expressed in dsk2 rpn1 was stable (right panel).  
Second, we used a genetic method to confirm the dependence of Dsk2 instability on the 
ubiquitin-proteasome pathway. A series of Ura3-fused Dsk2 constructs and their UBA mutant 
(Ura3-1-335) were made (Fig. 1D). The stability of these Ura3-fused constructs in yeast cells 
was evaluated by immunoblotting. Ura3-fused Dsk2 was stable, but Ura3-1-335 was unstable in 
YPH499 (summarized in Fig. 1D, left panel). These constructs were then transformed into a 
parental strain YPH499, and we tested whether Ura3-fused Dsk2 complemented the uracil 
auxotrophy of YPH499 based on its growth on plated of minimal medium without uracil, the 
complementation of which is an indication for the stabilization of Ura3-Dsk2 protein in cells. 
As expected, YPH499 expressing Ura3-Dsk2 grew and YPH499 expressing Ura3-1-335 failed 
to grow (middle panel), because Ura3-1-335 was unstable. The proteasome mutant pre2 strain 
expressing Ura3-1-335, however, did grow on plates of minimal medium without uracil (middle 
panel). The same result was obtained for rpn1 (right panel). These genetic results (summarized 
in the left panel) indicate that Dsk2 UBA mutant 1-335 became stable in the proteasome mutant 
strain. Therefore, the Dsk2 UBA mutants were degraded in the ubiquitin-proteasome pathway 
depending on the UBL domain. 
 
The UBL domain of Dsk2 is ubiquitinated in yeast cells.  
In the course of our experiments on yeast Dsk2, we detected endogenous Dsk2 with a laddered 
banding pattern on the immunoblot. As this pattern was reminiscent of ubiquitinated proteins, 
we tested the ubiquitination status of Dsk2. A pull-down experiment in which His6-T7-ubiquitin 
was precipitated with Talon resin, and the bound materials were immunoblotted with anti-Dsk2 
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antibody. Ubiquitin chains of Dsk2 were confirmed (Fig. 2A, lane 8).  
We next determined the region of Dsk2 that is ubiquitinated. All eight lysine residues of 
Dsk2 lie within the UBL domain (K8, K13, K28, K33, K49, K52, K72, K76) and these residues 
in the UBL domain are highly conserved from yeast to humans (Fig. 2B). We constructed an 
arginine-substituted mutant of the Dsk2 UBL domain (Dsk2-KR) in which the eight lysine 
residues were replaced by arginine (Fig. 2B, bottom). To test the ubiquitination status of 
Dsk2-KR in cells, Dsk2-KR was expressed in dsk2  as in Fig 2A, followed by a pull-down with 
Talon resin of the cell extracts and immunoblotting with anti-Dsk2 antibody (Fig. 2C). 
Compared with wild-type Dsk2 (lane 11), Dsk2-KR was not ubiquitinated (lanes 12, 13). Thus, 
the lysine residues in the UBL domain of Dsk2 are ubiquitinated in yeast. 
 
Ubiquitin chains of the Dsk2 UBL domain mediate Dsk2 own stability.  
We investigated whether ubiquitin chains are required for the instability of UBA-defective 
Dsk2. UBL/UBA double mutants [21] were constructed (Fig. 3A) to test for their degradation 
(Fig. 3B) as before. All of the double mutants; KR/GF343AA (lanes 10-12), KR/GS359AA 
(lanes 16-18), and KR/LL368AA (lanes 22-24), were stable in YPH499 (Fig. 3B). Degradation 
of Dsk2 via UBA domain, therefore, requires ubiquitin chains of Dsk2 UBL domain. Consistent 
with this stability, all of these mutants were not ubiquitinated in the cells (Fig. 3C, lanes 8-11). 
These results show clearly that Dsk2-KR recovers the instability of the Dsk2 UBA mutants. We 
therefore concluded that UBA-defective Dsk2 was degraded in the ubiquitin-proteasome 
pathway mediated by ubiquitin chains of the UBL domain. Wild-type Dsk2 was ubiquitinated, 
but still stable, suggesting that endogenous Dsk2 can escape from degradation even when it is 
fully ubiquitinated (see Discussion). 
 
Dsk2 ubiquitination affects in vivo ubiquitin-dependent protein degradation.  
UBL-UBA proteins such as Dsk2 function in the delivery of ubiquitinated substrates to the 
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proteasome. We investigated whether ubiquitin chains of the UBL domain affect Dsk2 function 
in yeast cells. 
First, the effect of ubiquitin chains in the Dsk2 UBL domain on protein degradation in vivo 
was examined by using the N-end rule substrate Leu- -gal. DSK2 disruption impairs degradation 
of Leu- -gal in the cells [17]. A single copy of wild-type Dsk2 or Dsk2-KR was expressed in 
dsk2   (Fig. 4A). Defective degradation of Leu- -gal in dsk2   restored by the expression of 
wild-type Dsk2, but was not by Dsk2-KR.  
 Second, the effect of ubiquitin chains on the interaction of Dsk2 with polyubiquitinated 
proteins in cells was examined. GST-Dsk2-KR was coexpressed with His6-T7-ubiquitin in 
yeast, and the GST pull-down was immunoblotted with anti-T7 and anti-Dsk2 antibodies (Fig. 
4B). Dsk2-KR decreased the ability to bind polyubiquitinated proteins in cells (lane 5), although 
the binding ability was not completely abolished. As a control, wild-type Dsk2 bound to 
polyubiquitin in cells (lane 4), but UBA deletion 78-335 did not (lane 7). Therefore, the 
ubiquitin chains of the UBL domain also affect the interaction between Dsk2 and 
polyubiquitinated proteins in yeast. Deletion of the UBL domain (78-373) bound to 
polyubiquitinated proteins (lane 6) (See Discussion). 
Next, the complementation of DSK2 disruption by Dsk2-KR was tested using the growth 
defect of dsk2 rad23 . A strain with deletions of both DSK2 and RAD23 is temperature-sensitive 
for growth although a disruption of DSK2 alone is viable [20]. A single copy of Dsk2-KR was 
expressed in dsk2 rad23  (Fig. 4C, left). Dsk2-KR had decreased ability to complement the 
temperature-sensitive growth of dsk2 rad23 , whereas wild-type Dsk2 was able to fully 
complement growth. 
Growth arrest of yeast and the accumulation of large amount of polyubiquitinated proteins 
in cells are caused by overexpression of wild-type Dsk2 in yeast [7,17], which seem to be 
involved in Dsk2 function in the ubiquitin-proteasome pathway. When the effect of ubiquitin 
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chains on the Dsk2-mediated growth arrest was examined, overexpressed Dsk2-KR failed to 
inhibit the growth as expected (Fig. 4C, right). Consistent with this, Dsk2-KR did not 
accumulate polyubiquitinated proteins in cells (data not shown). Thus, ubiquitin chains of the 
UBL domain are required for in vivo Dsk2 function. 
 
Discussion 
This paper shows that yeast Dsk2 is ubiquitinated via its UBL domain. Depending upon 
ubiquitin chains in the UBL domain, Dsk2 that is defective in the UBA domain were degraded 
by the ubiquitin-proteasome pathway. This instability was recovered by deleting ubiquitin 
chains in the UBL domain. The stability and function of Dsk2 are closely linked to the 
ubiquitin-proteasome pathway through ubiquitin chains of the UBL domain of Dsk2. 
 
Ubiquitin chains of the Dsk2 UBL domain are a signal for Dsk2 degradation in yeast cells.  
The UBL domain and the UBA domain interact with the proteasome and the polyubiquitinated 
proteins, respectively. UBA domain-defective Dsk2 protein, which fails to bind polyubiquitin 
chains of the degradation substrates, can bind to the proteasome via its UBL domain. As a 
result, such dysfunctional Dsk2 would occupy the proteasome receptor. In this condition, such 
dysfunctional Dsk2 must be degraded (eliminated) rapidly in cells. Our results show that 
ubiquitin chains of the Dsk2 UBL domain serve as a signal for Dsk2 degradation (Fig. 3). We 
suggest that the UBL domain-mediated Dsk2 degradation take part in eliminating dysfunctional 
Dsk2 from the receptor site of the proteasome.  
The UBL domain has eight lysine residues and the UBL domain sequence of Dsk2 has high 
similarity to ubiquitin (Fig. 2B). When the ubiquitination status of a series of lysine mutants was 
tested in more detail, the K28/K33 mutant was ubiquitinated but the K28R/K33R mutant was 
less with different molecular weight shifts (see Supplement data). It is thus likely that ubiquitin 
chains of Dsk2 are conjugated mainly through K28/K33 of the UBL domain. In the absence of 
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lysines in K28/K33, however, other K sites can be used to form different chains. Based on our 
preliminary experiment on K28R and/or K33R mutants, Dsk2 ubiquitination seems to depend 
mainly on K28 rather than K33 (data not shown). We suspect that K28 of the UBL domain 
(equivalent to ubiquitin K29) may be a probable candidate for a major chain linkage in the UBL 
domain, but further analysis is required on the molecular details. 
 
Dsk2 UBA domain may bind alternatively ubiquitin chains of the UBL domain and of 
polyubiquitinated substrates.  
The Dsk2 UBA domain in vitro binds both K48- and K29-linked chains [22], and the UBA 
domain interacts with the UBL domain intramolecularly [23]. The Dsk2 UBA in cells binds 
preferentially to K48-chains of polyubiquitinated substrates [7,17]. It is reasonable that 
UBL-UBA proteins undergo a conformation change between ‘open’ and ‘closed’ forms [16]. 
The ‘open’ form binds to K48-linked ubiquitinated substrates via the C-terminal UBA domain 
and to the proteasome via the N-terminal UBL domain, which acts as a delivery factor. 
Alternatively, the ‘closed’ form intramolecularly interacts between the UBL K28/K33-linked 
chains and UBA domains. Ubiquitin chains of the UBL domain may contribute to a 
conformational change of Dsk2 protein molecules. The difference of chain preference 
(K48/K28) could endow Dsk2 with a distinct property in the delivery pathway. 
Binding of UBL chains to its own UBA domain may affect its own stability. It is possible 
that the ‘stockpile Dsk2’ that fails to bind K48 chains of the substrates binds to the UBL 
K28/K33-chains through its interactions with the UBA domain, resulting in the escape of Dsk2 
from degradation. This protection may explain how the wild-type ubiquitinated Dsk2 is able to 
escape from own degradation by the proteasome. Indeed, wild-type Dsk2 is ubiquitinated, but 
stable in cells [20] (Figs. 1B, C, and 3B). In relevant to this, recent works suggest that the UBA 
domain guard ubiquitin receptors by preventing initiation of degradation at the proteasome [24]. 
Our data also show that the Dsk2 UBL domain lacking ubiquitin chains impaired the 
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degradation of Leu- -gal (Fig. 4A) and that in vivo Dsk2 function in yeast required the UBL 
ubiquitination (Fig. 4C). Moreover, the UBL domain lacking ubiquitin chains decreased the 
interaction of Dsk2 with polyubiquitinated proteins in cells (Fig. 4B, lane 5), indicating that 
ubiquitin chains of the UBL domain can help the interaction between the Dsk2 UBA domain 
and polyubiquitinated substrates. Interestingly, however, deletion of the whole UBL domain did 
not affect the binding between the UBA domain and the polyubiquitinated substrates (Fig 4B, 
lane 6). Ubiquitin chains of the UBL domain might negatively mediate the interaction of 
putative inhibitory protein(s) with the UBA domain. In contrast, it is unlikely that the UBL 
ubiquitin chains affect the interaction between Dsk2 and the proteasome, because we did not 
detect any difference on the binding ability between the Dsk2 wild-type and KR mutant (our 
preliminary result).  
Rad23 and Dsk2 both function in the delivery pathway. In case of Rad23, it has been 
already shown that the Rad23 stability is mediated by the UBA domain-dependent degradation 
[15]. Taken together with Dsk2 (this report), we suggest that ubiquitin chains of the UBL 
domain in UBL-UBA proteins play a distinct role in the ubiquitin-proteasome pathway. 
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Figure legends 
Fig. 1. UBA domain-defective Dsk2 is degraded through the ubiquitin-proteasome 
pathway.  
(A) The Dsk2 UBA mutant is unstable. The GST-version of Dsk2 deletions (lanes 3-8) was 
expressed in YPH499 and detected by immunoblotting with anti-GST antibody (upper panel) 
and anti-Cdc28 antibodies (lower panel) as a loading control. The stability of the mutants is 
shown on the right of a diagram of the Dsk2 constructs.  
(B) The UBA mutants became stable in the proteasome mutant. GST-Dsk2 and GST-LL368AA 
were induced by galactose in YPH499 (lanes 1, 2), pre2-75 (lanes 3, 4), and rpn1-821 (lanes 5, 
6) strains. Dsk2 and Cdc28 were detected by immunoblotting with anti-Dsk2 (upper panel) and 
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anti-Cdc28 antibodies (lower panel), respectively.  
(C) Instability of the UBA mutant was recovered by the proteasome mutation. Similar to (B), 
GST-Dsk2 and GST-LL368AA were induced by galactose in dsk2  and dsk2 rpn1-821, followed 
by immunoblotting with anti-Dsk2 and anti-Ddi1 antibodies (a loading control). Degradation 
was assayed at 30-min intervals.  
(D) Complementation of the uracil auxotroph by URA3-fused Dsk2. pRS314-URA3-DSK2 or 
pRS314-URA3-1-335 using the endogenous promoter was transformed into wild-type YPH499 
or proteasome mutants (pre2-75, and rpn1-821), respectively. Growth was tested in a minimal 
medium plate without uracil. A diagram of the URA3-fused Dsk2 mutants is shown, 
summarizing both the Ura3 complement abilities and stability. 
 
Fig. 2. The UBL domain of Dsk2 is ubiquitinated in yeast.  
(A) Dsk2 is a ubiquitinated protein. Wild-type Dsk2 in YEplac195 was co-expressed with 
His6-T7-ubiquitin in dsk2  (lanes 1-4), followed by pull-down with Talon resin and 
immunoblotting with anti-Dsk2 antibody (lanes 5-8). Vector denotes YEplac195. The arrow 
indicates the non-ubiquitinated form of Dsk2 that aggregates non-covalently with the resin.  
(B) Sequence alignment of the UBL domain in Dsk2 homologs. The gray regions indicate 
conserved lysine residues in the UBL domain. Eight lysine residues of the Dsk2 UBL domain 
were all replaced by arginine (Dsk2-KR), shown at the bottom.  
(C) The Dsk2-KR mutant lacks ubiquitin chains. The Dsk2 (lanes 2, 5, 8, 11) or Dsk2-KR 
mutant (lanes 3, 6, 9, 12, 13) in pEG-KG was co-expressed with His6-T7-ubiquitin. Cell extract 
(lanes1-6) and Talon resin pull-down (lanes 7-13) were immunoblotted by anti-Dsk2 antibody. 
Twofold-volume of Dsk2-KR sample was loaded (lane 13). Method is the same as described in 
(A). Vector denotes YEplac112 (control for His6-T7-ubiquitin). This result by His pull-down 
was also confirmed by GST pull-down of GST-Dsk2 version of the extracts, followed by 
immunoblotting with anti-Dsk2 antibody (data not shown). 
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Fig. 3. Ubiquitin chains of the UBL domain mediate instability of the Dsk2 UBA mutant.  
(A) Diagrams of the UBL and UBA double mutants. The K and R in the UBL domain indicate 
wild-type and the KR mutant, respectively. An asterisk in the UBA domain denotes the 
alanine-substituted UBA mutants (see the details at the bottom). Ubiquitination and stability of 
these mutants are summarized on the right.  
(B) The UBL and UBA double mutant is stabilized. Degradation of the UBL and UBA double 
mutants was assayed in dsk2 strain. Dsk2 and Dsk2-KR (lanes 1-6), UBA mutants (lanes 7-9, 
13-15, 19-21), and UBL/UBA mutants (lanes 10-12, 16-18, 22-24) in YEplac195 were 
expressed by galactose induction in dsk2 . After shut-off, the induction cell extracts were 
collected at 30-min intervals and immunoblotted with anti-Dsk2 and anti-mAb414 antibodies (a 
loading control).  
(C) Ubiquitination of the UBL and UBA mutant. The ubiquitination status of Dsk2 and their 
UBL and UBA mutants was examined. Ubiquitination of GST-Dsk2 was tested first, and then 
GST version of these mutants were co-expressed with His6-T7-ubiquitin in pre2-75, and 
analyzed as in Fig. 2. Wild-type Dsk2 (lanes 4, 7), UBA mutant (GS359AA and LL368AA) 
(lanes 5, 6), UBL mutant Dsk2-KR (lane 8), and the UBL/UBA double mutants (lanes 9-11).  
 
Fig. 4. Ubiquitination of the Dsk2 UBL domain affects ubiquitin-dependent protein 
degradation and Dsk2 function in vivo.  
(A) Protein degradation of N-end rule substrate. DSK2 or DSK2-KR was expressed in dsk2  
from a single-copy vector YCplac22 in the presence of galactose-induced Leu- -gal. After the 
induction was shut-off, cell extracts were taken at 20-min intervals. Each sample was 
immunoblotted with anti- -gal and anti-cdc2 antibodies (a loading control, a gift from H. 
Nishitani).  
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(B) Effect of UBL ubiquitination on the interaction between Dsk2 and polyubiquitinated 
proteins in cells. GST-Dsk2 and its mutants were co-expressed with His6-T7-ubiquitin in yeast. 
GST pull-down was immunoblotted by either anti-Dsk2 or anti-T7 antibodies.  
(C) Effect of Dsk2-KR mutant on yeast growth. (Left panel); complementation test of dsk2 . 
pRS316 expressing DSK2 or DSK2-KR from the endogenous promoter was transformed to 
dsk2 rad23  and their abilities to restore temperature-sensitive growth were tested by incubating 
in minimal medium minus uracil at 36oC for 3 days. Vector denotes pRS316. Expression levels 
were shown on the bottom. (Right panel); Dsk2-mediated growth arrest. Both multi-copy 
vectors YEplac195 and YEplac112 overexpressing DSK2 or DSK2-KR were transformed to 
YPH499 and incubated in minimal medium containing 2% glucose minus uracil and tryptophan 
at 30oC for 2-3 days.  
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Research Highlights  
 
> We show that the UBL domain of Dsk2 is ubiquitinated in yeast.  
>Dsk2 that is defective in the UBA domain is unstable.  
>Depending on Ub chains, the UBA-defective Dsk2 is degraded by Ub-proteasome pathway. 
>Dsk2 ubiquitination affects Ub-dependent protein degradation in vivo.  
> Ub chains of UBL domain mediate Dsk2 own stability and protein degradation in yeast.  
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